Incidence of V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience

Incidence of V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience

Objective Papillary thyroid carcinoma (PTC) accounts for 95% of all thyroid carcinomas. PTC is an epithelial tumor characterized by the proliferation of follicular cells with distinctive nuclear features, and is heterogeneous in terms of its carcinogenesis and behavior. PTC has been associated with...

Full description

Bibliographic Details
Main Authors:	Shoko Kure, Kousuke Ishino, Mitsuhiro Kudo, Ryuichi Wada, Marie Saito, Ryuta Nagaoka, Iwao Sugitani, Zenya Naito
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-11-01
Series:	Journal of International Medical Research
Online Access:	https://doi.org/10.1177/0300060519873481

Similar Items

Congenital hemophilia A diagnosed with postoperative hemorrhage after thyroidectomy for papillary thyroid carcinoma: a case report
by: Marie Saitou, et al.
Published: (2021-08-01)

The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
by: Yangsen Li, et al.
Published: (2022-07-01)

The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma
by: Rafael Selbach Scheffel, et al.
Published: (2020-08-01)

Retrospective study of BRAFV600E mutation and CT features of papillary thyroid carcinoma
by: Xiaoquan Hong, et al.
Published: (2024-01-01)

Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer
by: Marco Capezzone, et al.
Published: (2024-01-01)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.
by: Jian Sun, et al.
Published: (2016-01-01)

Preoperative detection of TERT promoter and BRAFV600E mutations in papillary thyroid carcinoma in high-risk thyroid nodules
by: Tatiana Marina Vieira Giorgenon, et al.
Published: (2019-03-01)

A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation
by: Jill Pancer, et al.
Published: (2019-03-01)

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation
by: Ying Han, et al.
Published: (2022-06-01)

Meta-Analyses of Association Between BRAFV600E Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma
by: Qing Zhang, et al.
Published: (2016-02-01)

BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma
by: Mohammadhossein Dadgarnia, et al.
Published: (2021-10-01)

Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto’s Thyroiditis
by: Qin Zhang, et al.
Published: (2017-07-01)

Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
by: Cahill, S, et al.
Published: (2007)

Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer
by: Irena Ivković, et al.
Published: (2022-12-01)

BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
by: Jennifer A. Silver, et al.
Published: (2021-11-01)

MRI-Based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma
by: Zheng T, et al.
Published: (2023-01-01)

Iodine nutritional status is not a direct factor in the prevalence of the BRAFV600E mutation in papillary thyroid cancer
by: Yan-Yu Lin, et al.
Published: (2023-01-01)

Highly prevalent V600E and low-frequency promoter mutations underlie papillary thyroid carcinoma in Koreans
by: Sue Youn Kim, et al.
Published: (2020-07-01)

Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
by: Jung Hyun Yoon, et al.
Published: (2020-01-01)

BRAF V600E and lymph node metastases in papillary thyroid cancer
by: Pan Chen, et al.
Published: (2020-10-01)

Comparative study between Immunohistochemistry and Molecular method in detection of BRAF V600E mutation in papillary thyroid carcinoma
by: Sarah Ali Darweesh, et al.
Published: (2023-12-01)

TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea
by: Min Jhi Kim, et al.
Published: (2022-10-01)

Coexistence of BRAFV600E mutation and EGFR overexpression is highly associated with adverse clinicopathological features of papillary thyroid carcinoma
by: Paunović Ivan, et al.
Published: (2020-01-01)

High Preponderance of BRAF V600E Mutation in Papillary Thyroid Carcinoma Among Filipinos: A Clinicopathologic Study
by: Gerard Anthony M. Espiritu, et al.
Published: (2019-01-01)

Deep Small RNA Sequencing of BRAF V600E Mutated Papillary Thyroid Carcinoma With Lymph Node Metastasis
by: Azliana Mohamad Yusof, et al.
Published: (2019-10-01)

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors.
by: Agnieszka Czarniecka, et al.
Published: (2015-01-01)

False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
by: Se Hyun Paek, et al.
Published: (2017-11-01)

Clinical outcome, role of BRAFV600E, and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?
by: Carmelo eNucera, et al.
Published: (2012-02-01)

Predicting BRAFV600E mutations in papillary thyroid carcinoma using six machine learning algorithms based on ultrasound elastography
by: Enock Adjei Agyekum, et al.
Published: (2023-08-01)

Positive BRAFV600E mutation of primary tumor influences radioiodine avidity but not prognosis of papillary thyroid cancer with lung metastases
by: Shuhui Huang, et al.
Published: (2022-11-01)

Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
by: Chenlei Shi, et al.
Published: (2016-01-01)

Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAFV600E Mutations in Papillary Thyroid Carcinoma
by: Yu-guo Wang, et al.
Published: (2022-04-01)

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
by: Meiling Huang, et al.
Published: (2019-07-01)

T-Box Transcription Factor 22 Is an Immune Microenvironment-Related Biomarker Associated With the BRAFV600E Mutation in Papillary Thyroid Carcinoma
by: Xubin Dong, et al.
Published: (2020-12-01)

Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAFV600E Mutation by Bioinformatics Integrative Analysis
by: Lucas Goedert, et al.
Published: (2017-05-01)

Predicting factors of central lymph node metastasis and BRAF V600E mutation in Chinese population with papillary thyroid carcinoma
by: Sheng Li Zhou, et al.
Published: (2021-07-01)

Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
by: Artur Kowalik, et al.
Published: (2017-01-01)

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
by: Changjiao Yan, et al.
Published: (2019-07-01)

Factors associated with BRAF V600E gene mutation in patients with undiagnosed papillary thyroid carcinoma by fine needle aspiration cytology
by: ZHANG Guozhi, et al.
Published: (2022-12-01)

Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.
by: Ah Young Park, et al.
Published: (2014-01-01)